share

6,9-Difluoro-11,16,17,21-Tetrahydroxypregna-1,4-Diene-3,20-Dione 21-Acetate CAS NO 4306-83-6


Unit Price:

CAS No.:4306-83-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

6,9-Difluoro-11,16,17,21-Tetrahydroxypregna-1,4-Diene-3,20-Dione 21-Acetate is a high-purity synthetic steroid derivative, serving as a critical pharmaceutical intermediate. Its value lies in its precise chemical structure, which is essential for the development and manufacturing of advanced corticosteroid-based therapeutics. This compound is primarily required by pharmaceutical R&D laboratories and production facilities focused on anti-inflammatory and immunosuppressant drugs.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of potent topical and systemic corticosteroids.
  • Research & Development: Used in medicinal chemistry for developing new steroid-based drug candidates with modified pharmacological profiles.
  • Active Pharmaceutical Ingredient (API) Synthesis: Integral in multi-step synthesis processes for final API production under Good Manufacturing Practice (GMP) conditions.
  • Reference Standard: Serves as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical manufacturing.
  • Biochemical Research: Utilized in studies investigating steroid receptor interactions and metabolic pathways.

Basic Information

Item Detail
Product Name 6,9-Difluoro-11,16,17,21-Tetrahydroxypregna-1,4-Diene-3,20-Dione 21-Acetate
CAS No. 4306-83-6
Molecular Formula C23H28F2O6
Molecular Weight 438.47 g/mol
Synonyms Difluprednate Impurity; Difluprednate Related Compound A; 6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione 21-acetate; 6α,9α-Difluoroprednisolone 21-Acetate; 6,9-Difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione 21-acetate; 6,9-Difluoroprednisolone 21-Acetate; Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,16,17,21-tetrahydroxy-, 21-acetate
EINECS Contact for details

Quality Control

Our 6,9-Difluoro-11,16,17,21-Tetrahydroxypregna-1,4-Diene-3,20-Dione 21-Acetate is manufactured and tested to meet stringent quality standards suitable for pharmaceutical applications. Each batch is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We ensure compliance with relevant pharmacopeial guidelines and support customer-specific validation requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which can affect stability and purity.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Loss on Drying ≤ 1.0%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.